Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Sabra Health Care REIT's Days Sales Outstanding for the
three
months ended in Jun. 2026 was 50.33.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Sabra Health Care REIT's liquidation value for the
three
months ended in Jun. 2026 was €-2,110.1 Mil.
Sabra Health Care REIT (FRA:SBC) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Sabra Health Care REIT's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sabra Health Care REIT Change In Receivables Related Terms
Sabra Health Care REIT Change In Receivables Historical Data
* Premium members only.
The historical data trend for Sabra Health Care REIT's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sabra Health Care REIT Change In Receivables Chart
Sabra Health Care REIT Change In Receivables Calculation
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-14.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Receivables of €-14.3 Mil mean?
Sabra Health Care REIT (FRA:SBC) has a Change In Receivables of €-14.3 Mil as of Jun. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Sabra Health Care REIT and its competitors.
Is Sabra Health Care REIT's Change In Receivables too high?
Sabra Health Care REIT's current Change In Receivables is €-14.3 Mil. Overall, Sabra Health Care REIT has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sabra Health Care REIT's Change In Receivables compare to NHI and HR?
Sabra Health Care REIT's Change In Receivables of €-14.3 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a REITs company?
A good Change In Receivables depends on the REITs industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Sabra Health Care REIT and its competitors. Sabra Health Care REIT's current Change In Receivables is €-14.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sabra Health Care REIT stock overvalued right now?
Based on GuruFocus' analysis, Sabra Health Care REIT (FRA:SBC) is currently considered Fairly Valued. The stock's GF Value™ is €18.09, compared to a current price of €17.70 — trading 2.2% below its estimated fair value. The current Change In Receivables is €-14.3 Mil. Sabra Health Care REIT's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Sabra Health Care REIT (FRA:SBC), the current Change In Receivables is €-14.3 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sabra Health Care REIT (FRA:SBC) Overvalued in 2026?
Based on GuruFocus' analysis, Sabra Health Care REIT stock appears to be undervalued.
The current stock price of €17.70 is trading 2.2% below its estimated GF Value™ of €18.09.
GuruFocus considers Sabra Health Care REIT to be Fairly Valued.
Key valuation signals for FRA:SBC:
Change In Receivables: €-14.3 Mil
GF Value™: €18.09 vs. price of €17.70 (2.2% below fair value)
No single metric tells the full story. See the FRA:SBC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.
74GF Score
Get the complete analysis for FRA:SBC
Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:SBC has been successfully added to your 
